Charity registration nurnber.. 1171373
BRITISH SKIN FOUNDATION
TRUSTEES, REPORT AND
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 0ECEM8ER 2025

British Skin Foundation
Contents
Page
Referentr and Administrdtive Detsils
Trustees. Report
Independent Auditorfs Report
Statement of Financial Acti¥ikne5
Comparatlve Ststement of Flnanclal Activlties
Staternent of Finoncial P05ityon
io
Statement of Cash Flows
Notes to the Ststement of Cash Flows
12
Note5 to the Financial Statements
13-23

British Skin Foundation
Reference and Administrative Details
For The Year Ended 31 December 2025
Trustees
Mr R (résigned 09101120251
Professor C Bunker- Honorary Secretary
Dr Y Bume
Mr H Drayton (resigned 09101120251
Ms E Erkal-Pa￿r- Chair Person
Professor E Healy (resigned 1110912025)
Mrs E Kohring (appointed 0910112025)
Dr R Murphy (appointed 08105120251 (restyned 1110512026)
Dr N Rèlan
Dr R Sarkany (resigned 08105120251
Dr B Sher9ill- Honorary Treèsurer
Mr J Stalley (appointed 09101120251
Mrs J Thompson laptK>inted 09101120251
Dr C Per￿tt (aP￿￿nted 12105120261
Charlty Numb•r
1171373
Prlnclpal Addr¢••
4 Fittroy Square
London
WIT 5HQ
Audltor¥
NKhols & Co (Accountsnryl ￿rnited
Unit 7 Mulberry Place
nnell Road
E￿harn
London
SE9 6AR
dgel

British Skin Foundation
Trustees. Report For The Year Ended 31 December 2025
The trustees present their report and the financi61 ststetnents for the year er￿ed 31 D￿rnber 2025.
ObJectSves and Actl¥lties
Alms and ObJectlv¢s
The Trust was set up in order to Trise funds and provide funds. either dirertly or by way of grants, to other5 for the purpose
of research into derrnatology the cause5 of skin d15ease5 and the po55ibilit￿ of prevention, alleviation, and cure.
Public Benefit
The trustees have referred to the guidantt contained in the Charity Commission's guidance on public beneflt when
reviewing the charity's aims and objectives and in planning its futu￿ activit*s. In particular. the trustees consider how
planned activities will contribute to the aims and objectives that have been set.
Achlevements and Performance
M•ln A¢hlevem¢nts
2025 saw the 8ritish Skin Foundation complete its three-year business plan. The plan was put in pla￿ to allow the charity
to grow In its three rnain areas of Fundraisingi Cornmunications and Grant Giving. Although Incorne In 2025 Is slightly down
on the previous year this Is explained by a large one-off payrnent from the National Institute of Health Research made in
2024 to support the Foundations Young Investigotor prograrnme. All areas of Income remained stable throughout the year,
thls has meant that the Increage In the charity's comrnunications budget as laid out in the business plan has not impacted
the charlty'$ grants programme or other core funttions of the BSF.
The Brltish Skin Foundation continued to demonstrète its Importance to sklTh disease research in 2025 by ontt again
delivering a comprehensive grants programme offering valuable seed fuThdiTrg to the Dematology research community. The
Foundation was able to match the previous year's grant commitments of rnore that £lm, moking new awards In Scotland,
the North of England, the West Midland5, London and the South of England.
There wert no unp￿di￿e￿ overheads during 2025. and cost-of-liviNJ salary incrtases meant the Charity remained efficlent
and able ro maintain its commirment to Ivnding high quality. peer reviewed skin disease research.
Corporate donations continued to be the largest sir¥Jle income St￿aM for the BSF. This year's figure of £715,083 ha5
increased by £IOO,000 since last year and this steady Income category allows the charity to predlct grant output for the
year. Pharrna also continue5 to support the charity. Oue to Industry guideline5 limiting the ways In which Pharrna can fund
charltles, the BSF recelves grnnts to support its public educabon progrnmme5.
2025 Saw Events income increase by 30% on the previou5 year. This area of fundrai51ng continues to be important both
strategically and financially and serves as an indicètor of public engagement. Total Events income for the year was
£246,850. This year-on-year increase is seen by the charity as a significant success in whèt the Third Sector conslders a
difficuir fundraising category for small charities.
Le9acy Income rose sharply to £57.939 an Increase of 278%. Thls Income category although unpredictable Is seen as
potentially important source of fundraising and as part of the business plan. the chority has invested in new prornotlonal
rnaterials aimed at securing further legacie5 and gifts through wills.
The Derrnatology community Continues to supwrt the elonty. In 2025 the annual donation Frorn the Brit15h Association of
Dermatologist5 IBADI increased from E200.000 to £230.000. This donation 15 again ring fenced for Dermatology research
and can not be used to support BSF running costs. The BSF contlnues to jointly fund research work in assoclation wlth the
Medical R￿earch Council and receives funds from the BAD to support the UK Kerntlnocyte Collaboratlon IUKKCCI. The BSF
also receives fundlng from Indivldual Derrnatologtsts as well as donations from pnvate dermatology clinlcs.
The recent business plan placed emphasis on an increased investment in communications. 2025 saw that inve5trnent used
to great effect through the charity5 larye5t sun awarene55 carnpaign. The succe55 of the carnpaign was evident through
increased webslte, social media and public enga9erneTrt. The charity'5 profile increase was also reflected in approaches from
Phèrmè and potential torporate partnews. Through this greater level of invÈ5tment. the BSF Communications Department
continues to make the Foundation a leading source for all matters contemiw skin health.
dge2

British Skin Foundation
Trustees. Report (continued)
For The Year Ended 31 December 2025
FUNDRAISING STANDARD INFORMATION
A5 a registered charity funding skin disease and skin cancer re5earih. Britlsh Skin Foundation actively fundrai5es by
canvè551ng SUPPOrt frorn the public, industry. and philanthropic tru5t5. Its fundrni51ng artivities are undertaken by employed
staff wlthout the use of external third pèrty fundTaisers. These staff work within the guidelines set out by the Chèrlty
Commlsslon and wlthin the parameteTS of the chanty's osyn fundrnisin9 policy. During this accounting period, the charity
has received no complaints pertaining ro its fundtsising practices or its Staff. The chanty does not cold call or place p￿SSUre
on donors to give and It does use third part￿ or professional fundraising companies to attract support.
Flnanclal Revlw
Fln•n¢l•l P¢sltlon
The chanty's pnncipal sources of funding are donations and legac￿. The assets of the charity are mainly held In no-n5k
investrnent accounts at four un￿lated eritish financ￿1 institutions. The assets a￿ hehl in cash because the chority needs
ready acc￿5 to fund5 to rneet grant cornrnitments.
The chanty has also Invested in a 115ted Investment fvnd and are monrtoring tts perforrnance. The value at the year end
was £173.713 12024.. £159,344).
Regetveg Pollcy
The British Skin Foundation will maintain sufficient reserves to ensure fifianeial stablllty. Each year m)nies whlch a￿ not
already committed to reserves or grants, or required for runnin9 the orgènisation, ¥Yill be made available for new awards.
As there Is always a delay between the grantiThJ of awards and the call for funds. a substantial positive balance wlll remaln
in the bank. If there are insufficlent stsitable applications for grnnts. the monles will be carrled over to the next year.
Unrestricted funds Invested in tangible fixed assets, listed investments and cash increased from £3,154,187 to É3,231,992
during the year. Restricted fund5 Invested in cash fell frorn £740,796 to £616,554 during the year.
structure, Governance ond Monagement
Govtrnlng Document
The charftable incorporated oryanisation I"CIO"I was registered with the Chanty Comrnissioners by Trust Deed on 30th
January 2017 under the name"British Skin Foundation" The CIO has tsken over the *(ivlties of the charity 'The Brltish
Skln Foundation. {registe￿d charity number 3138651 on the 5th June 2020. as part of ) restrutturing of the ch8rlty.
New frustees may be appointed at any time either by way of re(Aacement or addition. Appointments are made by a
resolution of a meeting of the trustees provided that a memorandum declaring such appointment or discharge shall be
signed as a deed elther at a rneetlng by the person presldlng or In some other manner dlrected by the meeting and attested
by two persons present at the meeting.
Trustees are recruited elther on personal recommendation or, Whe￿ appropriate, through advertlsing. Care15 taken to
rnaintain a balanTr betsyeen the business 6n(J rnedicol experience 5ki115 contributed by the trustees. References are
taken up on potential trustees and they are wuired to attend a briefin9 tsn the charity's activities given by the
administraror. where they are provided with background infomation. copies of the latest audited accounts. and the latest
Charity Commission guidance.
The trustees Oversee the pay and remuneration of ihe CEO Matthew Paley which is benchrnarked against Industry standards
nd based upon perforrnance and an anThuol review.
The trustees have revievled the rna]or nsk5 facing the charity and taken action to rnanège those r15ks. The major risks are a
fall in income due to difficulties in the corporate an(J Financial rnarkets and possible ernployee fraud. The possibility of fraud
is minimised by only the trustees being signatories on rhe bank atcounts. and robust bank account security. In additlon. the
Trustee Lndemnity Insurance Policy includes cover against possible employee fiaud.
Key Manogement Rernuneration
The total amount of employee benefits {including employer pension contributions) received by key management personnel
for their services to the Charity was £80,875 (2024.. £75,604).
dge3

British Skin Foundation
Trustees. Report (continued)
For The Year Ended 31 December 2025
statement of Trustees. ResponsSbllltles
The trustee5 are responsible for preparitvj the Tru5tees' Report and the finanaal 5tatetnents in accordance with 6pplic6ble law
and United Kingdom Attounting Standards (United Kingdom GÈnÈrally Attepted Attounting Pratticel.
The law applicable to charities in Eryland and Wale5 wJire5 the trnstees to Prepa￿ financiol statements for each financial
year which give a true and fair view of state of affairs of the tharity and of intoming resourtes ènd applitation of
resources of the charity for that period.
In preparing the financial statements the trustee5 are reqUI￿d to..
select suitable accountin9 policies and then apply them consistentlyi
observe the methods and principles in the Charity SORP 2019 IFRS1021.'
make judgments and accounting estimates that are ￿SOnable and pnJdent,'
state whether applicable accounting standards have been followed., subject to any departu￿5 disclosed and explained
in the financial statements,.
prepare the financial staternents on the going concern basis unle55 it is inappropriate to pre5urne that the charity will
continue In operation.
The trustees are respon51ble for keeping adequate accounbng records whith disclose with reasonable accuracy at anythme the
financial position of the charity and to enable thern to ensure that the accounts comply with the Charities Act 2011, the
Charitie5 (Accounts and Report51 Regulations 2008 and the provisions of the tnjst deed. They are also responsible for
safeguarding the assets of the eharlty and hence for takin9 ￿8$0￿￿ble steps for the p￿VentIOn and detettion of fraud bnd
other irregularities.
The trustees are responsible for the maintenance and integrity of the charity and finanool inforrnation included on the
charlty's ¥vebsite. Legislation In the United King¢Jom governing the p￿paratIOn ènd dissemination of flnanclal statements may
dlffer from legislatlon in other Jurisdlttions.
The trustees. report was approved by the board of trusttts aTrJ slgned on Its behalf bv-
Professor C Bunker
Trustee
2911012026
dge4

Independent Auditor's Report
to the Members of
British Skin Foundation
Oplnlon
We have audited the financial statetnents of Britlsh Skin Fwndation Ithe"charity"I for the year ended 31 Decernber 2025
which comprise the Statement of Financièl Artivities (including Income and Expenditure Account). Statetnent of Financial
Posltion, Stètement of Cash Flows ènd the related notes. Intluding a summary of $19nificant actounting policles. The flnancial
reporting framesyork that has been applied In their preparation is applicable law and Unlted Kingdom Accounting Standards
Iunited Kingdom Generally Accepted Accounting Prxticel. including FRS 102 Yhe Financial Reporting Standard applicable In
the UK and Republic of Ireland"
In our opinlon the flnancial statements..
give a true and fair view of the state of the charity's afPdirs as at 31 December 2025 and of Its Incoming resources and
application of resources. for the year then ended:
have been properly prepared in accordance v41th United Klngdom Generally Accepted Accountlng pract1￿.. and
have been prepared in accordan￿ wlth the requlrements of the Chèritles Att 2011.
Basls for Oplnlon
We conducted our audit In accordantr with Internotional Stsndords on Auditing IUKI IISAS IUKII and applicable law. Our
responsibilities under those standards are further descnbed in the Auditor'5 res￿nSibIlitieS for the audit of the financial
statements section of our report. We are Indepen(Jen¢ of the charity in 6ccord6nce with the ethical requiretnents that 4re
relevanr to our audit of the financial statements in the UK. includin9 the FRC'S Ethical Standard. and we have fulfllled our
other ethlcal responsibilities In accordance with these requirements. We believe that the audlt evldence we have obtalned Is
sufficlent and appropriate to provide a bas￿ tor our Opin￿n.
Con¢luslons Relatlng to Golng Concern
In auditing the financial statements, we have concluded that the trustee5' use of the golng concem ba515 of accounting In the
preparation of the financiol statements is 3ppropriate.
Based on the work we have performed, we have not Identified any rnatenal uncertaintie5 relating to events or conditions that,
individually cr collectivelyi may cast Sl9nifiunt doubt on the charity's ability to contsnue as a going concern for a period of at
least L2 rncnths from when the finarKial staternents are authorised for issue.
Our responsibilitles and the responsibilities of the trustees with respect to golThJ concern are described in the relevant
5ectlons cf this repcrt.
other Inforniatlon
The trustees are responslble for the other information. The other information eomprises the Information Included In the
Annual Report. other than the financial statements and our Report of the Independent Audito￿ thereon.
Our cplnlon on the financial staternent5 does not cover the other inforrnation and, except to the extent otherwise expllcitly
stated In our report, ¥ve do not expres5 any forrn of a55urance conclusion thereon.
In connection with our audlt of the financial ststements, our responsibility is to re&J the other informatlon and, In doing so,
consider whether the other information is materially Inconsistent with the financial staternents or our knov41edge obtained in
the audit or otherwise appears to be matenolly misstated. If we Klentify such material iricon51Stencies or apparent ffl4terial
misstatements, ¥Ye are required to determine whether this gives rise to è materièl misstatement in the financial ststements
themselves. Ir, based on the work WÈ have perftsm￿. we conclude that there is a material misstatement of this other
information, we are required to report that I￿t. We have nothing to report in this regard.
Matter¥ on Whi¢h We Are Required to RepL¥rt by Exception
We have nothing to report in respect of the following rnatters in relation to which the Charitie5 (Accounts and Report51
Regulations 2008 require us to report to you il. In our opinion..
the information given in the Trustees, Report is inconsistent in any material respert with the financlal statements,. or
sufficient accounting records have not been kept,. or
the financial ststements are not In agreement with the accounting records or rturns,. or
we have not received all the iDforrnation and explonatiOn5 we require for our audit.
Page 5

Independent Auditor's Report (continued)
to the Members of
British Skin Foundation
Responslbllltles of Trustees
A5 explained tnore fully in the Trustee5' Responsibilities Statetnent Set out page 2-4. the trustee5 are resPOn5ible for the
preparation of the financial statements and for ￿Ing satisfied that they give è true and fair view, and for suth intemal control
as the trustees determine is necessary to enable the prepèration of finantsal statements that are free from materlal
misstatement, V4hether due to fraud or error.
In preparing the finèntial statemÈtTrt5, the trustees are responsible for assessTng the charity's ability to tontinue as a going
concern, disclosing, as applicable, matters relèted to going contem and usin9 the going toncem bèsis of accounting unless
the trustees either Intend to liquidate the charity or to cebse operatsons. or have no realistsc alternative but to do so.
Audltor'* Resp4nslbllltles for th¢ Audlt of the Fln•rt¢l•l Stst¢ments
We have been appointed as auditors under Section 144 of the chant￿ Act 2011 and report in accordance with the Act and
relevant regulatyons made or having effect thereunder.
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free frorn material
rnisstatement, whether due to fraud or error, and to issue an audito￿5 report that Include5 our opinion. Reasonable assurance
is a high level of assurance. but Is not a guarantee that an audit condurted in accordance with ISAS IUKI will always detect
rnaterial tni55tstement when it ex15ts. MisstaterTbents con orb5e frorn fraud or error and a￿ considered material if, Individually
or in the aggregate, they could rea50nobly be expected to influence the econornic decisions of users taken on the bas15 of
rhese financial statements.
Irregulariti￿, including fraud, are Instance5 of non*ompliantt with lows ar￿ ￿u￿tIOns. We design procedures in line with
our responsibilities, outlined obove. to detect material rnisstaternents in re5pe£t of Irregularities, Inclu(Jin9 fraud. The specific
procedure for thls engagement and the extent to which these art capable of deterting irregularities, including fraud Is
detailed below..
enqulry of staff. those tharged with governance and the charity'5 legal advisers (where deerned netessaryl,.
obtained an understanding of the legal and regulatory frarnework that the chanty operates In, focusing on those law5
and reguloticn5 that had a matenol effect on the financwl statements or that had a fundamental effect on the
operatlOn5 of the charity from our profes510nal and sector e¥pener*e.
reviewing minutes ef meet1n95 of those charyed with governorKe.
reviewing accounts disclosu￿$ and testing w supporting documentation to assess compllance wlth applicable laws and
regulatlons.
performing audit work over the risk of management override of controls. including testing of Journal entries and other
adjustments for appropriateness. evaluatin9 the rètionale of significant transattions outside the normal course of
buslness, and revSewlng accountlng estlmates for blas.
Because of the inherent Ilrnitatlons of an audit, there is a risk that we will not detect all irregulantles, includlng those leading
to a rnaterial mi55tatement in the financial Statements or non-compliance with regulation. This risk incred5es the more that
compliance with a law or regulation is removed from the evefits and tran5action5 refiected in the financial 5taternent5, a5 we
will be less likÈly to betome awère of instantes of non-compliante. The risk is also greater regarding irregularities octurring
due to fraud rather than error, as fraud involves intentional concealment, forgery. collusitsn. omission or misrepresentation.
A further description of our responsibilities for audit of the financial statement5 is located on the Financial Reporting
Countil's website at Ws¥w.fr¢.org.uklauditorsresponsibilities. This description forms part tsf our Report of the Intlependent
Auditors.
dge6

Independent Auditor's Report (continued)
to the Members of
British Skin Foundation
Use Of Our Report
Thi9 reptirt is tnade 501ely to the charity'5 trustees. a5 8 b￿¥. in accordance with Part 4 of the Charitie5 (Accounts and
Report51 RegulÈtlOn5 2008. Our audit work has been undertaken 50 that WÈ might state to thÈ tharity's trustÈe5 those
matters that we are reouired to state to them in an èuditor's report and for no other purpose. To the fullest extent permitted
by la¥Y, we do nor accept or assume responsibility to anyone other Ihan thÈ chanty and the charity's trustees as a body. for
our audlt work, for this report, or for the opinions we have fomed.
Nichols & Co (Accountsncyl Limited
3011012026
Nichols & Co (Accountancy) Limited
Llnit 7 Mulberry Place
Pinnell Road
Eltham
London
SE9 6AR
dge7

British Skin Foundation
statement of Financial Activities
For The Year Ended 31 December 2025
2025
2024
Vnrestricted Restrlrted
lunds
funds
Total
funds
Total
funds
Notes
INCOME AND ENDOWMENTS FROM:
Donations and legacie5
Other trnding activitie5
Investrnents
1.123.566
274.788
27.577
115.029 1.238,595 1,775,822
33,062
307,850
203,710
27,577
24,514
1,425,931
148,091 1,574,022 2,004,046
EXPENDITURE ON:
Raising funds
Charitable a¢tlvltles'.
Charitsble Actlvitles
Support Cost
{32.8101
132,8111
141,3491
11.305.649) 1272.332} 11.577,9811 11,405,049)
1106.1901
1106,1901 1101,0981
11,444.6491 1272,3331 11.716,9821 11,547,496)
NET IEXPENDITURE)IINCOME
{18,7181 1124,2421 1142,9601
456,550
Gains on revaluatlon of flxed assets
14.369
14,369
7,712
NET MOVEMENT IN FUNDS
RECONCILIATION OF FUNDS:
Total funds brought fO￿ard
14,3491 1124,2421 1128,5911
464,262
3,380,378
740,796 4,121,174 3,656,912
TOTAL FUNDS CARIUED FORWARD
20
3.376.029
616,554 3,992,583 4,121,174
The notes on pages 12 to 23 forni part of these financial statements.
dge8

British Skin Foundation
Comparative Statement of Financial Activities
For The Year Ended 31 December 2025
2024
Unrestrlrted Restricted
funds
tunds
Total
funds
Notes
INCOME AND ENDOWMENTS FROM:
Donations and legacie5
Other trnding activitie5
Investrnents
1.203.801
203.710
24,514
572,021 1,775,822
203,710
24,514
1,432,025
572,021 2,004,046
EXPENDITURE ON:
Raising funds
Charitable a¢tlvltles'.
Charitsble Actlvitles
Support Cost
141.3491
141,3491
1955.9691 1449,0801 11,405,049)
1101.0981
1101,0981
11,098.4161 1449,0801 11,547,496)
NET INCOME
333,609
122,941
456,550
Gains on revaluatlon of flxed assets
7,712
7,712
NET MOVEMENT IN FUNDS
RECONCILIATION OF FUNDS:
Total funds brought fO￿ard
341,321
122,941
464,262
3,039,057
617,855 3,656,912
TOTAL FUNDS CARIUED FORWARD
3.380.378
740,796 4,121,174
The notes on pages 12 to 23 forni part of these financial statements.
dge9

British Skin Foundation
statement of Financial Position
As At 31 December 2025
2025
2024
Unrestrltted Restricted Totsl
lunds
tunds
tunds
Total
funds
Notes
FIXED ASSETS
Tangible Assets
Investrnents
13
14
6.181
173.713
6,181
173,713
6,660
159,344
179,894
179,894
166,004
CURRENT ASSETS
Debtors
15
341.652
3.052.098
341,652
395,478
627,006 3,679,104 3,788,055
Cash at bank and in hand
3,393.750
627,006 4,020,756 4,183,533
Credltors: Amounts Falllng Due Wlthln One Ye•r
16
1197,6151 110,4521 1208,0671 1228,3631
NET CURRENT ASSETS ILIA8IiITIESI
3.196.135
616,554 3,812,689 3,955,170
TOTAL ASSETS LESS CURRENT iIABILfTIES
3,376.029
616,554 3,992,583 4,121,174
NET ASSETS
3,376,029
616,554 3,992,583 4,121,174
FUNDS OF THE CHA
Restricted Funds
Unrestricted Funds
616,554
740,796
3,376,029 3,380,378
TOTAL FUNDS
20
3,992,583 4,121,174
On behalf of the board
Dr B Sherglll
Trustee
2811012026
The notes on pages 12 to 23 forni part of these financlal statements.
Page 10

British Skin Foundation
statement of Cash Flows
For The Year Ended 31 December 2025
2025
2024
Cash flows from operatlng actl¥ltle$
Net cash (used Inllgenernted from operntions
1135.0241
176,680
Net Cash (used inllgenerated from operating ocbvitie5
1135,0241
176,680
Cash flows from Investing activitles
Purchase of tangible assets
Interest received
Dividends received
11,6691
22,656
5,086
14781
22,793
9,827
Net cash generated from Investlng acrivifies
26.073
32,142
IDecrea5ellincrea5e in cash and cash equivalents
Cash and cash eouivalents at beginnirvJ of year
1108.9511
3.788.055
208,822
3,579,233
Cash and cash equivalents at end of year
3,679,104
3,788,055
Page 11

British Skin Foundation
Notes to the Statement of Cash Flows
For The Year Ended 31 December 2025
l. Reronciliotion of (expenditure)lincorne to Cash (used in)Igenerated from operJtion5
2025
2024
Net lexpenditurellincorne
Adjustments for..
Interest incoffle
Intome from investrnents
1142,9601
456,550
122,6561
14,9211
2,148
120,9441
17,6231
1,812
Depreciation of tsngible a55ets
Movement5 working c6pitsl..
Decrei5e/llncreasel in trade and other debtors
Decrei5e in trade and other creditor5
53,661
120,2961
(252,3541
17611
Net cash Iu5ed Inl/generated from opernt￿n5
1135,0241
176,680
2. Cash and cash equlvalents
Cash and ¢a$h equivalents, as stated In the Statement of Cash Hows. rela*s to the followlng items in the Balance Sheet..
2025
2024
Cash at bank and In hand
3,679,104
3,788,055
3. An•ly•l• of ¢h•nge• In net fvnd•
As•tL
January
2025
C•¥h flow*
A5at31
De¢emb¢r
2025
Cash at bank and In hand
3.788.OSS
1108.9511
3,679,104
Page 12

British Skin Foundation
Notes to the Financial Statements
For The Year Ended 31 December 2025
l. General Information
British Skin Foundation Is a charitable incorpoTrted oryanisation regtstered with the Charity Commission, registered charity
number 1171373. The principal address is 4 Fitzroy Squa￿, London, WIT SHQ.
2. Accountlng Pollcles
2.1. Basls of Preparatlon of Flnanclal Statemertts
The charity constitutes a public benefit enbty a5 defi[￿￿ by FRS 102. The financial 5t8tetnents have been prepared in
ccordance with Accountitvj and Reporting by Charities.. Staternent of Recomtnended Practice applicable to charitie5
preparing their accounts in actordante with the Financièl Re￿rting Standard applicable in the UK and Republlc of
Ireland issuÈd in ottober 2019, the Finantial Reporting Standard applitable in the United Kingdom and Republic of
Ireland IFRS 1021, the Charities Act 2011 and UK Generally Accepted Accounting Prnctice.
The financlal statements are prepared on è going contem basis under the historical cost convention. modified to
include certain items at fair value. The finantial statements a￿ p￿ented in sterting which is the funttional currency of
the charity and rounded to the Thearest É.
The significant a¢¢ounting wllcies applied in the p￿parat￿)n of these fina￿la1 statements a￿ set out below. These
policles have been consistently applied to all years presented unless otherwise stated.
2.2, Golng Concern DlxlMyr¢
The financial statements have been prepared on a going Co￿ern basis as the trustees believe that no rnate￿al
uncertointies exist. The trustee5 hove consKlered the level of funL15 held an(1 the expected level of incorne an(J
expenditu￿ for 12 months from authorising these financial statements. The budgeted income and expendlture Is
suffleient with the level of reservesfor the charity to be able to continue as a 90in9 ¢oncem.
2,3, Fund Ac¢ountlno
Unrestricted funds are avallable for use at the discretion of the trustees ln fijrtherance of the general objectlves of the
charity and whlch have not been designated for other purposes.
Rest￿cted funds are funds which ale to be used in accordaKe with specific restrictlons Imposed by donot5 or whlch
have been raised by the charlty for particular purposes. The cost of ralsing and adminlstering such funds are charged
against the specific fund. The aim and use of each restncted fund is set out in the notes to the financial statements.
2.4. Incomln9 Resources
All ineoming ￿SourceS are incluOeJ In the Ststement of Finaneial Artivities ISOFAI v4hen the charity is legally entitled
to the income after any performance conditions have been met. Ihe amounr can be Measu￿ reliably and it is
probable that the income will be received.
2.5. R¢sour<es Expended
Llabillties are reccgnised as expenditure as soon as there is o legal or constructive obligation cornmlttlng the charity to
that expenditure, it is pmbable that a trnThsfer ol econornic benefits will be required In settlernent and the arnount of
the obligation can be measured reliably. Expenditure 15 accounted for on an accrua15 basis and ha5 been classified
under he6ding5 that aggregate all cost related ttk the cotegory. Where costs cannot be directly attributed to particular
headings they have been allocated to activilies on a basis consistent with the use of resources.
Grant5 offered subject to conditions whith have not been met at the year end date are noted as a cornmltrnent but not
accrued 45 expenditure.
2.6. Tangible Fixed A55ets ond Deprecialion
Tangible fixed assets are measured at cost less accumulated depreclatioTh and any accumulated Impalrment losses.
Depreclation Is provlded at rates calculated to write off the cost of the fixed assets, less their estimated residual value,
over their expected useful live5 on the following bases-
Fixtures & Fittings
Computer Equipment
IO% on cost
20% on cost
2.7. Investments
Investrnents are recognised initially * fair Val￿ whth is normally the trdrwrtion pnce excluding transaction costs.
Subsequently. they are measured at fair value with changes reco9nised In 'net 9aln5111055esl on investments, in the
SOFA If the sh4res are publicly traded or their fair value can otherwse be tneasured reliably. Other inve5trnents are
measured at C05t le55 itnpairtnent.
Page 13

British Skin Foundation
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2025
2.8. Taxation
As a ￿gIstered charity, the organisation is exernpt from income and capital gains tsx to the extent that its income and
gains are applicable to charitable purpose5 only. Value Adde(J Tax is not recoverable by the charity, and is therefore
Included within the relevant costs in the Ststement of Finanoal Acbvities.
2.9. Employee Benefits
When employees have rendered service to the charity. short-tem employee benefits to which the empk>yees are
entitled are recognised at the undiscounted amount e¥pected to be paid in exchange for that service. The charity
operates a defined contribution plan for the benefit of its employees. Contributions are expenses as they become
payable.
2.10. Debtors and creditors receivablelpayable within one year
Debtors and treditors with no stated interest rate and rÈteivable or payèblè within one year a￿ ￿Corded at
transaction price. Any losses arising from impairment are recognised in expenditu￿.
3. Income trom Don•tlons •nd Leg•¢1
2025
Unrestrleted Restrlrted
Totsl
funds
funds
funds
Donatlons and gllts..
Oonarions from individuals
Donatlons from organlsatio
16.696
715.083
i.ooo
57.939
16,696
715,083
I,ooo
57,939
Legacies
other..
Trust donations
BAD donations
Grant donation$
SHA donatlon$
4.169
286.000
4,169
286,000
15,000
142,708
15.000
100.029
42.679
1,123.566
115,029
1,238,595
2024
Unrestricted Restrirt¢d
Tot•1
fund5
fund5
funds
Donations and gifts..
Donations from individuals
16.595
613.536
16,595
613,536
8,044
15,340
Donation5 from oryanis4tioThs
Gift èid
Legacies
Other..
Trust donations
15.340
24.033
256.000
87.745
182.508
509,364
533,397
256,000
150,402
182,508
BAD donations
Grant donations
62.657
SHA donations
1,203,801
572,021
1,775,822
Page 14

British Skin Foundation
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2025
4. Income from Other Trading Artibryties
2025
Unrestrlcted Restrlcted
funds
funds
Total funds
Sponsorships
Fundraising events
61.000
213,788
61,000
246,850
33,062
274.788
33,062
307,850
2024
Unrestrlttsd Restrlrted
funds
funds
Totsl funds
Sponsorships
Fundraising events
14,000
189,710
14,000
189,710
203.710
203,710
5. Invutment Income
2025
2024
Unrestrlcted Unr*strlct•d
fund¥
fundl
Interest on short-tern depDsIts
Oivldends from investments
22,656
4,921
19,095
5,419
27,577
24,514
6. Net Income/(Expendlture)
The net lexpenditvrellincome is stated after chargingll¢rtditingl:
2025
2024
Depreciation of tangible fixed assets- owned
2.148
1,812
7. Analysls ol Expendlture
2025
Grant
funding tyf
•LtiVbties
{see note 8) (see note 91
A¢tiviti¢s
ndertaken
dlrectlv
Support
Totsl
Raising funds
Charitable Activities
32,811
558,106
32,811
1,577,981
106,190
1,019,875
Support Cost
106,190
590.917
1.019,875
106.190
1,716,982
Page 15

British Skin Foundation
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2025
2024
Grant
fundlng of
Support
artl¥btles
costs
(see note 81 (see note 91
Actlvltles
undertaken
Irertlv
Total
Raising fund5
Charitsble Artivitie5
Support C05t
41.349
451,176
41,349
1,405,049
101,098
953,873
101,098
492.525
953.873
101,098
1,547,496
8. Grants Payable
2025
2024
Grants to
Grants to
Instltutlons Instltutlons
Charitsble Actlvllles
1,019,875
953,873
Grants paid to institutitsns, included above, are as follo*s.'
2025
2024
02515117 - Unlverslty of Dundee
0321slL8 - Unlverslty College London
037lr118 - University of Dundee
04319118 - Imperial College
0991r119 - George Kravvas
0041slL9 - 8eatson Institute For Cancer Research
0031s120 - Unlverslty of Hull
00715120 - Newcastle University
0081r120 - Newcastle University
0091r120 - Newcastle Unlversity
OISls120 - University of Bath
01715120 - University of Birmingham
037lr120 - University of Manchester
04115120 - University of Nottingham
OOllr121 University of Southampton
OOLlk121 University of Dundee
MRC-10 - Medic61 Rese4rch Council
001185FSTART122 - University College LorKlon
0231yi122 University OF Manchester
02815122 - University of Cambridge
034lyi122 - University of Oxford
MRC-09 - Medical Rese4rch Council
38,880
3,651
2,045
7,083
16,645
208
7,024
5,087
17,794
17.995
25,735
25,972
30,375
25,162
28,333
21,250
20,250
28,333
20,065
98,000
21,667
51,489
40,162
31,560
50,133
3,829
16191
6,383
22,495
41,845
.CONTINUED
14,167
21.250
7,083
10.032
10,833
41
20,081
30,420
26,422
00918SFBPG/19 University of Southompton
042lyi119 - King's College London
Olllyi120- Queen Mary University of Londowb
025ls120 - Queen Mary University of London
10,000
1,536
44,989
14,166
Page 16

British Skin Foundation
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2025
019IBSFBAD/21 - University Hospitsls &'miingham Charity
006lrl22 - Kin9'5 College London
00915122 - King'5 College London
012/rl22- Middlesex University
0141s/22 - Queen Mary University of London
0211s122 - University of Hull
037/rl22 - Queen Nary University of London
002IBSFSG/23 Imperial College London
007/BSFSG/23 T￿nIty College Dublln
009/BSFSG/23 - University of Lincoln
OID/BSFSGI23 - Unlversity of Manchester
014/BSFSG/23 Guy's and St Thomas. NHS Foun(lation Trust
0191BSFSGI23 Institute of Cancer Research.. Royal Cancer Hospital
002/BSFBAD/23 - The Royal Marsden NHS Foundation Trust
003/BSFBADI23 - Unlversity of Oxford
004/rl23 Queen Nary University of London
0041s123 - Glasgo¥Y Caledonian University
0091$123 - Leeds Beckett university
0181B5FSGI24 University of Oxford
012/B5FSGI24 King's College London
OOI/BSFBSPAD/24 - Oxford University
8016$ - Universlty of Nottlngham
021/B5MD/22 . King's College London
0081s/22 - Klng's College London
OOI/RSMI23 - King's College London
ooiir123 Royal United Hospital Bath NHS
0021F123 Trlnlty College Dublin
002/s/23 - Universlty of Edinburyh
0031rl23 Cardiff University
0031W23 - University of Bradford
0051$123 - City St George's University Of London
00819123 - The University of Manchester
Oll1s/23 - Nesycastle University
NRC-11 - Medi¢al Researth Council
10,000
42,122
27,162
39,766
21,250
16,303
10,105
9,900
9,997
ID,000
ID,000
ID,000
9,939
ID,000
9,991
11,155
1,603
7,917
9,670
9,500
6,562
38,715
28,104
28.333
31,552
40,420
10,125
26,929
31,667
1,880
9.994
39.161
30,000
15,500
31,000
IS.833
33,586
15,833
23,750
31,666
31,667
20.881
9,996
9,620
19,132
1,732
13,424
25,484
14,015
27,770
34,566
9,874
9.891
10,000
9.971
OIO/BSFSG/24 Univetsity of Southampton
01618SFSG/24 University of Hull
002IBSFBSSVDI24 - King'5 College London
OOl1s/24 - University of Bristol
002/f/24 - King's Collège London
0061yi124 - Norfolk Norwich Vniver5ity Hospital NHS FourKlatioTr Tn
00815124 - Kin9'5 College London
OIOlrl24 - Kin9'5 College London
012/rl24 - Imperial College London
OIA/BSFSG/25 - The University of Manchester
002/BSFSG/25 - The LJniver5ity of Manchester
006/BSFSG/25 - Cardiff University
007IBSFSG/25- Trinity College Dubli
.CONTINUED
Page 17

British Skin Foundation
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2025
OID/BSFSG/25- ￿Ver[XX)I lohn Mth)re University
015IBSFSG/25 - University of Birmingham
009/BSFSG/24- Le￿5 Beckett University
9,987
9,983
8,914
1,019,875
953,873
9. Support Costs
2025
2024
Support Cost Support C05t
General adrninistration..
Insurance
Subscriptlons
Payroll fees
Bank charge5
Office accommodaticn charge5
Sundry expense5
Depreciation..
Depreciation of fixture5 and fittings
Depreclation of cornputer equipment
Governance costs..
Trustees, expenses
Audlt fee5
Audltors, rernuneratlcn for noTh audlt work
3.218
23,242
1,434
1,747
56,000
1.398
3,228
17,743
1,385
1,779
56,000
2,238
809
1,339
808
1,004
537
8,919
7,$47
593
9,030
7,290
106.190
101,098
lo. Audltor'• R¢mun¢r•tlon
Remuneration recelved by the chorlty's audltors aTrJ thelr assodale5 durlng the year was a5 follows..
2025
2024
Audlt Servlc•s
Audlt of the company's financial statements
8,919
9,030
other Servlce4
other non-audit seNlces
7,547
7,290
Page 18

British Skin Foundation
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2025
11. Stsff Costs
Staff costs were as follows..
2025
2024
Wages and salaries
Social security costs
Other pension costs
369,410
36,834
18,696
348,486
33,049
17,510
424,940
399,045
The number of employees whose employee benefits lexdudlng employer penslon costs) for the ￿portIng perlod exceeded
£60,000 was..
2025
2024
£70,000 to £79,999
£80,000 to £89,999
12. Av•ra9• Number of Ernploy•
Average number of employees during the year was.. 812024: 8}
13. T•nglble Assets
Flxtures &
FItVngS
Computer
Equlpment
Totsl
Cost
As ar i January 2025
Additions
8.067
5,025
1,669
13,112
1,669
As at 31 December 2025
8.087
6,694
14,781
Depreclatlon
As ar i January 2025
Provided durin9 the period
2.893
809
3,559
1,339
6,452
2,148
As at 31 Oecember 2025
3,702
4,898
8,600
Net Book V•lue
A5 at 31 December 2025
4.385
1,796
6,181
As ar i January 2025
5.194
1,466
6,660
14. Investments
Llsted
Cost or Valuatlon
A5 at l January 2025
Revaluations
159,344
14,369
As at 31 December 2025
173,713
.CONTINUED
Page 19

British Skin Foundation
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2025
Provlslon
A5 at l January 2025
As at 31 Oecember 2025
Net Book Value
As at 31 Detetnber 2025
173,713
As at l January 2025
159,344
There VIÈ￿ no Investment assets outside the VK.
The fair value of11sted Investrnents Is deterrnined by referentt to the quoted pritt for idenbcal assets In an active market at
the balance sheet date.
15. Debtors
2025
2024
Due wlthln one ye•r
Prepayment5 an(1 accrued Inco￿
Gift aid recoverable
Other donotion5
186,152
22,000
133,500
80,733
20,000
294,745
341,652
395,478
16. Credltor•: Amounts Falllng Due Wbthln One Ye•r
2025
2024
Trade creditors
other creditors
32,264
2,541
201
16,176
368
95,833
60,682
141
2,407
795
15,120
327
123,750
85,823
Credit Card
Accruals and deter￿￿ inwme
Accruals
Defer￿￿ Income
Grants payable
208,067
228,363
17. Deferred Income
Deferred income movements In the year were as follows..
2025
2024
86lance at the 5t6rt of the period
Income deferred in the current peri
Arnount5 released in incotne frotn previou5 periods
123.750
95,833
1123,7501
69,500
123,750
169,5001
Balance at the end of the period
95,833
123,750
Deferred income represents corporate don*iots for use of the Brit15h Skin Foundation logg on pr￿￿￿5 for periotJ5 after 31
December 2025.
Page 20

British Skin Foundation
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2025
18. tspital Comrnitments
É3,080,262 of grant funding commitments have not beeTh accrued in the balance sheet as performance related conditions
have not been met. The charity holds sufficient cash deposits to fund these grant commitrnents. There Is untrrtainty as to
when th￿e commitments will be settled, as they depend on the progress of each medical ￿earch project.
Grant commitments as at 31st December 202S..
Ref
Total Value
Outstanding
33,435
25,829
2017
02S/s117
037lr118
85,000
75,197
2018
2019
0421yl119
79.902
14.600
2020
007lsl20
Olllyl/20
0251$120
037lrl20
0411s120
85,000
89,978
85,000
Bl,000
85,000
L.484
22.495
28.988
10.125
7.083
2021
OOllr121
Bl,000
10.774
2022
MRC-10
OOIIBSFSTART122
00815122
00915122
01419122
0211s122
0231y1122
02815122
0371r122
65,000
75,707
85,000
85,000
85,000
85,000
80,325
85,000
80,839
5,417
12,636
45,839
29,734
35,417
37.145
10,041
17,633
30,315
2023
OOll1123
002/f123
00215123
0031r123
00315123
0041r123
00415123
00515123
00815123
009ls123
01115123
62,000
62,000
95,000
80,544
95,000
81,000
95,000
95,000
95,000
95,000
95,000
46,500
3L,DOO
79,167
46,958
79,167
59,720
66,469
71,250
63,333
55,416
63,333
2024
MRCII
0041BSFSG124
OOlls124
002lf124
0031s124
004ls124
0051s124
006lyi124
008ls124
OIOls124
62,544
10,000
95,000
71,000
95,000
95,000
95,000
101,936
95,000
95,000
41,663
10,000
93,268
57,576
95,000
95,000
95,000
76,452
80,895
95,000
.CONTINUED
Page 21

British Skin Foundation
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2025
OIOlr124
OL21r124
00316SFs￿A/24
92.(M)O
92.000
99,975
64,230
57,434
99,975
2025
00318SFBSSVD125
OD216SFBSPAD125
001/6SFs￿ASGl2S
0081BSFSG125
OII/BSFSG125
0061SHASOC125
00116SFF125
0031r125
0031yi125
0041yi125
0061s125
0081s125
0091s125
Olllr125
0131r125
OL515125
20.000
10,000
9.955
9,778
9,777
90,074
71.000
89.840
101,856
101.981
95.000
95.000
95.000
91,329
91.876
95.000
20,000
10,000
9,955
9,778
9,777
90,074
71,000
89,840
101,856
101,981
95,000
95,000
95,000
91,329
91,876
95,000
£3,080,262
19. P¢n*lon Comrnltments
The charlty operates a defined contrlbutlon pensloTr plan for Its employees. The amount recogThlsed as an expense In the
perlod was £18,696 12024.. £17,510).
The defined contribvfion liability is all¢Kated ro unrestrKted fvnds and 1$ a direct cost within charitable artlvitles.
20. Movement In Funds
Asati
Janu•ry
2025
Asat31
December
2025
Galns and
losse•
In¢•me
Expendlture
Unrestrlcted
General..
General unresrrirted fund
3.380.378
1.425.931
11.444.649)
14.369
3,376,029
Restrlcted funds
Restricted Fund
740.796
148.091
1272.3331
616,554
Total funds
4.121.174
1.574.022
11.716.982)
14.369
3.992,583
Asati
January
2024
Asat31
D¢¢*mb¢r
2024
Gains and
losses
Income
Expendlture
Unrestrlcted funds
General..
General unrestricted fund
Restricted funds
3.039.057
1.432.025
11.098.416)
7.712
3.380,378
.CONTINUED
Pdge 22

British Skin Foundation
Notes to the Financial Statements (continued)
For The Year Ended 31 December 2025
Restricted Fund
617.855
572.021
1449.0801
740,796
Total funds
3.656,912
2.004,046
IL.547.4961
7,712
4,121,174
Fund description
al Unrestrirted funds
Unrestricted funds are available to spend on activities that hjrther arw purpose of the charity.
bl Restricted funds
Donatlons re￿IVed to be used to fund speclflc skln dlsease ￿arch pmjects.
21. Transactlons wlth Trustees
None of the trustees ￿ceiVed any remuneration or ony ott*r benefits from an ernployrnent with the charity or a related entity
during the current or prevlous year.
Durlng the year the expenses ￿1mbur$ed to the trustees or pald dlrtly to thlrd parfjes were as follows..
2025
2024
Travel
537
593
Nurnber cf tru5ttts relmbutsed for expenses during the year wè5 4 12024.. 21
22. Related Party Dlsclosure
The Brltish Skln Foundation Chlef Executive. Matthew Patey. and Trustee, Jarnes Stalleyi are director5 of the Skln Health
Alliance (Cornpany Registration No. 074458201. The Skin Health Alliance Jonatetl £140.000 to the Bdtish Skin Foundation In
2025 plus a contribution of £2,708 to¥Yards media services used Jointly {2024.. £182,5081-
Page 23